Improving brain cancer treatments

Donations

Raised so far
$ 400,000
Our Goal
$ 400,000

This project focuses on improving treatment and survival for children with some of the most high-risk brain cancers.

Pharmaco-phospho-proteo-genomics of paediatric high-grade glioma (HGG)

This project focuses on improving treatment and survival for children with some of the most high-risk brain cancers.

Brain cancer accounts for 40 percent of paediatric cancer deaths. There has been no significant improvement in survival rates in decades. High-grade gliomas (HGG) are particularly aggressive and deadly brain tumours.

Genetic mutations alter the activity of proteins controlling the growth and survival of cancer cells. For children diagnosed with HGG, we are yet to understand how these pathways function.

This project, led by Associate Professor Matt Dun, will combine the investigation of tumour genomics and protein architecture to establish patient-specific therapeutic options with the greatest chance of survival.

Recipient

Associate Professor Matt Dun

Institute

The University of Newcastle, Hunter Medical Research Institute

Funding

$300,000 October 2021 to September 2024

Funding details Image

Thank you from the researcher

Researcher block Image
Associate Professor Matt Dun

Associate Proffessor Matt Dun is an NHMRC research fellow from The University of Newcastle in the Shcool of Biomedical Sciences and Pharmacy. He has been supported by TKCP since October of 2021. Assoc. Prof. Dun has personal experience of childhood cancer with his daughter affected. Matt's daughter Josie was diagnosed with deadly brain stem cancer, Diffuse Instrinsic Pontine Glioma (DIPG) at 2 years of age. Josie died 22 months later. This experience saw Dr Dun shift focus from blood cancer to brain cancers where he continues his research efforts to increase understanding regarding the pathophysiology of the disease and improve survivability.

Researcher Profile

Partners of this project

Your details

Donation on behalf of *

Select a donation frequency

  • One off donation
  • Monthly
  • Quarterly

Choose your Hexagon

100,000 Pearl
50,000 Platinum
25,000 Gold
10,000 Silver
5,000 Bronze
1,000 Teal

OR enter your donation amount

Select a project to support

Acute myeloid leukaemia (AML) project image

Acute myeloid leukaemia (AML)

Funding required: $563,118
Currently raised: $30,745

Acute myeloid leukaemia (AML)

A highly fatal blood cancer in adults and children. By adding a newly developed NAMPT inhibitor to standard of care treatment, this project can pave the way towards a more effective treatment of poor outcome adult and paediatric AML.

Improving brain cancer treatments project image

Improving brain cancer treatments

Funding required: $400,000
Currently raised: $355,000

Paediatric high-grade glioma (HGG)                                                       

This project focuses on improving treatment and survival for children with some of the most high-risk brain cancers

Supporting clinical trials project image

Supporting clinical trials

Funding required: $750,000
Currently raised: $66,444

Providing access to international clinical trials and additional clinical trial expertise                                                                                 

ANZCHOG international trials set up and manage the clinical trials for bran new kids' cancer treatments, giving kids access to the very latest therapies.

Recovering from treatment project image

Recovering from treatment

Funding required: $300,000
Currently raised: $72,800

RECOVER – Responding to late effects in survivors of childhood cancer

Empowering young survivors of childhood cancer to transition to adulthood with the knowledge, skills and resources required to manage their ongoing health needs.

Tackling the effects of treatment project image

Tackling the effects of treatment

Funding required: $305,000
Currently raised: $33,094

Treatment toxicity can cause infertility

Developing genetic risk prediction of long term infertility from childhood cancer therapies leading to informed decisions and application of preventive measures.

Translating research project image

Translating research

Funding required: $186,000
Currently raised: $186,000

Sarcoma (bone & soft tissue cancer)

Clinical translation of laboratory tested CAR T cell therapy into Phase 1 trials for paediatric treatment of sarcoma.

Let us choose

Message to The Kids' Cancer Project

Subscriptions

I authorise The Kids' Cancer Project to contact me about

Proceed to Make a Donation

Your donation amount

(AUD) Edit Amount

Thank you for making a donation to the campain.

Payment Details

2% will be added to your total cost and continue for any recurring payments.

For donations over $10,000 please use "Pay on Invoice" method

Summary:

Total Amount:
$



Card Number
CVV/CVC
Card Holders Name

Pay with PayPal